Welcome to LookChem.com Sign In|Join Free

CAS

  • or

321596-55-8

Post Buying Request

321596-55-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

321596-55-8 Usage

General Description

4,6-Dibromo-3-hydroxypyridine-2-carboxylic acid methyl ester is a chemical compound that is commonly used in organic synthesis and medicinal chemistry. It is a methyl ester derivative of 4,6-dibromo-3-hydroxypyridine-2-carboxylic acid, containing two bromine atoms, a hydroxyl group, and a carboxylic acid. 4,6-Dibromo-3-hydroxypyridine-2-carboxylic acid methyl ester is often used as a building block for the synthesis of various pharmaceuticals and drug candidates, due to its potential as a bioactive molecule. It has also been studied for its antifungal and antibacterial properties. Additionally, 4,6-Dibromo-3-hydroxypyridine-2-carboxylic acid methyl ester has been investigated for its potential use in the development of new agrochemicals and crop protection products. Overall, this compound has versatile applications and is of interest in multiple fields of research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 321596-55-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,5,9 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 321596-55:
(8*3)+(7*2)+(6*1)+(5*5)+(4*9)+(3*6)+(2*5)+(1*5)=138
138 % 10 = 8
So 321596-55-8 is a valid CAS Registry Number.

321596-55-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 4,6-dibromo-3-hydroxypyridine-2-carboxylate

1.2 Other means of identification

Product number -
Other names methyl 4,6-dibromo-3-hydroxypicolinate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:321596-55-8 SDS

321596-55-8Relevant articles and documents

NOVEL ISOINDOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

-

Paragraph 0185; 0187, (2020/01/22)

Disclosed are a novel isoindoline derivative, a pharmaceutical composition and use thereof. The compound of formula I, or the pharmaceutically acceptable salt, solvate, polymorph, co-crystal, stereoisomer, isotopic compound, metabolite or prodrug thereof disclosed in the invention can regulate the generation and/or activity of PDE4 and/or TNF-α so as to effectively treat cancer and inflammatory diseases.

Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases

Hecker, Scott J.,Reddy, K. Raja,Lomovskaya, Olga,Griffith, David C.,Rubio-Aparicio, Debora,Nelson, Kirk,Tsivkovski, Ruslan,Sun, Dongxu,Sabet, Mojgan,Tarazi, Ziad,Parkinson, Jonathan,Totrov, Maxim,Boyer, Serge H.,Glinka, Tomasz W.,Pemberton, Orville A.,Chen, Yu,Dudley, Michael N.

supporting information, p. 7491 - 7507 (2020/08/21)

Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among these are the class B (metallo) enzyme NDM-1 of Enterobacteriaceae and the class D (OXA) enzymes

TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

-

Page/Page column 22, (2019/12/28)

The present invention relates to Tricyclic Heterocycle Compounds of Formula (I): (I) and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, R3, R4, R5, R6 and n are as defined herein. The present invention also relates to compositions comprising at least one Tricyclic Heterocycle Compound, and methods of using the Tricyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 321596-55-8